Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury

H Khan, K Sharma, A Kumar, A Kaur, TG Singh - Inflammation Research, 2022 - Springer
Introduction Ischemia–reperfusion injury (IRI) is the inexplicable aggravation of cellular
dysfunction that results in blood flow restoration to previously ischemic tissues. COX …

Neuropeptides: Potential neuroprotective agents in ischemic injury

P Saklani, H Khan, S Gupta, A Kaur, TG Singh - Life Sciences, 2022 - Elsevier
Aim Ischemic damage to the brain is linked to an increased rate of morbidity and mortality
worldwide. In certain parts of the world, it remains a leading cause of mortality and the …

α-Lipoic acid, an organosulfur biomolecule a novel therapeutic agent for neurodegenerative disorders: an mechanistic perspective

H Khan, TG Singh, RS Dahiya, MM Abdel-Daim - Neurochemical research, 2022 - Springer
Abstract Lipoic acid (α-LA)(1, 2-dithiolane3-pentanoic acid (C8H14O2S2) is also called
thioctic acid with an oxidized (disulfide, LA) and a reduced (di-thiol: dihydro-lipoic acid …

Understanding mechanistic aspect of the therapeutic role of herbal agents on neuroplasticity in cerebral ischemic-reperfusion injury

A Bangar, H Khan, A Kaur, K Dua, TG Singh - Journal of …, 2024 - Elsevier
Ethnopharmacological relevance Stroke is one of the leading causes of death and disability.
The only FDA-approved therapy for treating stroke is tissue plasminogen activator (tPA) …

Calpain inhibitors as potential therapeutic modulators in neurodegenerative diseases

H Khan, N Garg, TG Singh, A Kaur, K Thapa - Neurochemical Research, 2022 - Springer
It is considered a significant challenge to understand the neuronal cell death mechanisms
with a suitable cure for neurodegenerative disorders in the coming years. Calpains are one …

Intervention of neuroinflammation in the traumatic brain injury trajectory: In vivo and clinical approaches

NK Prabhakar, H Khan, AK Grewal, TG Singh - International …, 2022 - Elsevier
TBI has been one of the top causes of death and morbidity worldwide, yet despite enormous
efforts to discover neuroprotective therapeutics for this serious disease, no beneficial …

Mechanistic insight on autophagy modulated molecular pathways in cerebral ischemic injury: from preclinical to clinical perspective

P Kalra, H Khan, A Kaur, TG Singh - Neurochemical Research, 2022 - Springer
Cerebral ischemia is one of the most devastating brain injuries and a primary cause of
acquired and persistent disability worldwide. Despite ongoing therapeutic interventions at …

Peroxisome proliferator-activated receptor-gamma (PPAR-ɣ): molecular effects and its importance as a novel therapeutic target for cerebral ischemic injury

A Mannan, N Garg, TG Singh, HK Kang - Neurochemical Research, 2021 - Springer
Cerebral ischemic injury is a leading cause of death and long-term disability throughout the
world. Peroxisome proliferator-activated receptor gamma (PPAR-ɣ) is a ligand-activated …

Targeting ferroptosis in ischemia/reperfusion renal injury

K Thapa, TG Singh, A Kaur - Naunyn-Schmiedeberg's Archives of …, 2022 - Springer
Renal I/R injury is a severe medical condition contributing to acute kidney injury (AKI),
leading to rapid kidney dysfunction and high mortality rates. It is generally observed during …

Pharmacological postconditioning by protocatechuic acid attenuates brain injury in ischemia–reperfusion (I/R) mice model: implications of nuclear factor erythroid-2 …

H Khan, AK Grewal, TG Singh - Neuroscience, 2022 - Elsevier
Abstract Ischemia–reperfusion (I/R) injury often follows cardiovascular aberrations that
predispose the patient to be neurological and cognitive abnormalities. Pharmacological …